prikaz prve stranice dokumenta Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine
  Download
PDF 877.48 KB
Scientific paper - Original scientific paper
Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine
Advances in Medical Sciences, 67 (2022), 2; 379-385. https://doi.org/10.1016/j.advms.2022.09.003
Skonieczna, Magdalena; Adamiec-Organisciok, Malgorzata; Hudy, Dorota; Dziedzic, Arkadiusz; Los, Laura; Skladany, Lubomir; Grgurević, Ivica; Filipec-Kanižaj, Tajana; Jagodzinski, Miczyslaw; Kukla, Michal; Nackiewicz, Joanna

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Skonieczna, M., Adamiec Organisciok, M., Hudy, D., Dziedzic, A., Los, L., Skladany, L. ... Nackiewicz, J. (2022). Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine. Advances in Medical Sciences, 67. (2), 379-385. doi: 10.1016/j.advms.2022.09.003

Skonieczna, Magdalena, et al. "Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine." Advances in Medical Sciences, vol. 67, no. 2, 2022, pp. 379-385. https://doi.org/10.1016/j.advms.2022.09.003

Skonieczna, Magdalena, Malgorzata Adamiec Organisciok, Dorota Hudy, Arkadiusz Dziedzic, Laura Los, Lubomir Skladany, Ivica Grgurević, et al. "Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine." Advances in Medical Sciences 67, no. 2 (2022): 379-385. https://doi.org/10.1016/j.advms.2022.09.003

Skonieczna, M., et al. (2022) 'Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine', Advances in Medical Sciences, 67(2), pp. 379-385. doi: 10.1016/j.advms.2022.09.003

Skonieczna M, Adamiec Organisciok M, Hudy D, Dziedzic A, Los L, Skladany L, and sur.. Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine. Advances in Medical Sciences [Internet]. 2022 September [cited 2024 April 30];67(2):379-385. doi: 10.1016/j.advms.2022.09.003

M. Skonieczna, et al., "Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine", Advances in Medical Sciences, vol. 67, no. 2, pp. 379-385, September 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:020762. [Accessed: 30 April 2024]

Metadata
Title (english)Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine
AuthorMagdalena Skonieczna
AuthorMalgorzata Adamiec-Organisciok
AuthorDorota Hudy
AuthorArkadiusz Dziedzic
AuthorLaura Los
AuthorLubomir Skladany
AuthorIvica Grgurević
AuthorTajana Filipec-Kanižaj
AuthorMiczyslaw Jagodzinski
AuthorMichal Kukla
AuthorJoanna Nackiewicz
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Purpose: Human carcinoma cells with different p53 status exposed to a combination of bioactive substances, resveratrol and berberine, revealed different responses in cell viability via p53-dependant apoptosis pathway activation. Materials and methods: Using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, we investigated various and opposing effects in hepatocellular carcinoma cells, Hep-G2 and Hep-3B with different p53-status. Results: Cells decreased in viability after treatment with dose-dependent concentrations of resveratrol and berberine. Hep-3B p53 mutants were more sensitive in comparison to the p53 wild type Hep-G2 cell line. A synergistic effect was observed after treatment of Hep-3B cells with a combination of resveratrol/berberine ratios in favor of resveratrol (2:1, 3:1). The results suggest that an effective concentration of berberine, in the presence of resveratrol, could be decreased even to 50% (half the IC50 for berberine) in cancer treatment. Combined treatment with berberine and resveratrol, at the investigated concentrations and fractions, significantly reduces the viability of wild type p53 Hep-G2 and null p53-mutant Hep-3B cells by 20% and 40%, respectively. Conclusions: Stronger toxic effects on viability and proliferation were observed in Hep-3B cells what is consistent with the assumptions that null p53-mutants activate apoptosis canonical pathway. In conclusion, p53 status in human hepatocellular cancer cell lines modulates responses to plant-derived therapies.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleAdvances in Medical Sciences
Numberingvol. 67, no. 2, pp. 379-385
p-ISSN1896-1126
DOIhttps://doi.org/10.1016/j.advms.2022.09.003
URN:NBNurn:nbn:hr:105:020762
Publication2022-09
Document URLhttps://linkinghub.elsevier.com/retrieve/pii/S1896112622000372
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2023-08-24 09:23:35